*ST Sailong faces imminent delisting as *ST Cuihua's stock plummets over 20%.

Today's market saw significant developments for several companies facing financial distress and regulatory scrutiny.

Earnings & Performance

• *ST Huaxi Co., Ltd. (002630) forecasts a net loss of RMB 40 million for H1 2026, down from a profit of RMB 36.17 million last year, citing market risks and high financial expenses.
• Jiecai Intelligent Technology Co., Ltd. (301248) anticipates a net loss of RMB 220 million to RMB 440 million for H1 2026, attributed to increased investments in AI computing.
• Tangrenshen Group Co., Ltd. (002567) projects a net loss of RMB 850 million to RMB 1.05 billion for H1 2026, significantly worsening from a loss of RMB 5.99 million last year.
• *ST Bangjie Co., Ltd. (002634) expects a net loss for H1 2026 due to high fixed costs and a decline in the textile sector.
• *ST Weiming Co., Ltd. (002581) announces a forecasted net loss of RMB 85 million to RMB 98 million for H1 2026, reflecting ongoing litigation and operational challenges.

Deals & Restructuring

• *ST Sailong Co., Ltd. (002898) issued its seventh risk warning as its stock enters the delisting arrangement period, with delisting set for the next trading day after the period ends.
• ST Cuihua Co., Ltd. (002731) is under investigation by the CSRC for failing to disclose periodic reports, following a 20% drop in stock over three days, raising delisting concerns.
• ST Longda Co., Ltd. (002726) announced it cannot repay its convertible bonds due to insufficient cash, entering pre-restructuring proceedings.
• Fulin Precision Co., Ltd. (300432) plans to issue shares to CATL, raising between RMB 2.0 billion and RMB 3.05 billion to fund various projects, including new energy vehicle components.

Regulatory & Governance

• Guotai Environmental Protection Co., Ltd. (301203) disclosed that its subsidiary received an administrative penalty for bid rigging, expected to reduce profits by RMB 1.857 million.
• Longshine Technology Group Co., Ltd. (300682) confirmed changes in controlling shareholders following the termination of concerted action agreements among shareholders.

Other Notable Developments

• Sichuan Kelun Pharmaceutical Co., Ltd. (002422) announced that its TROP2 ADC drug met primary endpoints in a Phase III trial for lung cancer treatment.
• Yao Yi Gou Co., Ltd. (300937) reported abnormal trading fluctuations with a stock price increase exceeding 30% over three days, despite recent financial losses.
• Tianjin Guoan Mengguli New Materials Science and Technology Co., Ltd. (301487) received approval for issuing shares to specific objects, pending CSRC registration.
• Dapuwei Co., Ltd. (301666) forecasts a significant turnaround from loss to profit for H1 2026, driven by AI data center investments.